» Articles » PMID: 38003896

Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes

Overview
Journal J Pers Med
Date 2023 Nov 25
PMID 38003896
Authors
Affiliations
Soon will be listed here.
Abstract

The rupture of hepatocellular carcinoma (rHCC) is uncommon but causes sudden life-threatening bleeding. Selective transarterial embolization (STAE) is an effective bleeding-control option. The optimal embolic agent is unknown, and data on the use of cyanoacrylate glue are lacking. The objective of this study was to report the outcomes of cyanoacrylate-lipiodol embolization for rHCC. We retrospectively reviewed the files of the 16 patients (14 males; mean age, 72 years) who underwent emergency cyanoacrylate-lipiodol STAE at a single center in 2012-2023 for spontaneous rHCC. All 16 patients had subcapsular HCC and abundant hemoperitoneum. The technical success rate was 94% (15/16). Day 30 mortality was 19%; the three patients who died had severe hemodynamic instability at admission; one death was due to rebleeding. Liver enzyme levels returned to baseline by day 30. No rebleeding was recorded during the median follow-up of 454 days in the 10 patients who were alive with available data after day 30. Larger prospective studies with the collection of longer-term outcomes are needed to assess our results supporting the safety and effectiveness of cyanoacrylate-lipiodol STAE for rHCC. Randomized trials comparing this mixture to other embolic agents should be performed.

References
1.
Prigent F, Guillen K, Comby P, Pellegrinelli J, Falvo N, Midulla M . Selective Arterial Embolization of Renal Angiomyolipomas with a N-Butyl Cyanoacrylate-Lipiodol Mixture: Efficacy, Safety, Short- and Mid-Term Outcomes. J Clin Med. 2021; 10(18). PMC: 8470153. DOI: 10.3390/jcm10184062. View

2.
Chevallier O, Comby P, Guillen K, Pellegrinelli J, Mouillot T, Falvo N . Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: A systematic review and meta-analysis. Diagn Interv Imaging. 2021; 102(7-8):479-487. DOI: 10.1016/j.diii.2021.03.004. View

3.
Zhou C, Zu Q, Wang B, Zhou C, Shi H, Liu S . Efficacy and prognostic factors of transarterial embolization as initial treatment for spontaneously ruptured hepatocellular carcinoma: a single-center retrospective analysis in 57 patients. Jpn J Radiol. 2018; 37(3):255-263. DOI: 10.1007/s11604-018-0799-z. View

4.
Zhou C, Zu Q, Liu X, Wang B, Zhou C, Shi H . Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients. Diagn Interv Radiol. 2020; 26(3):223-229. PMC: 7239369. DOI: 10.5152/dir.2019.19049. View

5.
Zhang W, Huang Z, Che X . Emergency versus delayed hepatectomy following transarterial embolization in spontaneously ruptured hepatocellular carcinoma survivors: a systematic review and meta-analysis. World J Surg Oncol. 2022; 20(1):365. PMC: 9673318. DOI: 10.1186/s12957-022-02832-7. View